Drug Profile
Noribogaine
Alternative Names: 12-hydroxy-ibogamine; 12-OH-ibogamineLatest Information Update: 28 Dec 2018
Price :
$50
*
At a glance
- Originator DemeRx
- Class Alkaloids; Analgesics; Small molecules
- Mechanism of Action NMDA receptor antagonists; Opioid receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Opioid-related disorders
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for phase-I development in Opioid-abuse in New Zealand (PO, Capsule)
- 28 Nov 2016 Noribogaine is still in phase I trials for Opioid abuse in New Zealand
- 18 May 2016 Chemical structure info added